Claris Bio
PrivateLast Round
Series B
Jul 28, 2026
Total Funding Raised
$175M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Claris Bio is a biotechnology company that specializes in the development of topical formulation technology for the treatment of orphan ophthalmic disorders and corneal diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Claris Bio Comparables
Compare Claris Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Selagine, Inc. | 86% | |
| TearSolutions | 86% | |
| iView Therapeutics | 85% | |
Claris Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jul 28, 2026 | ||||
| Series A | Jan 4, 2024 |
Claris Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Janus Henderson Group | Series B, Series A |
| RA Capital Management | Series A |
| Mass General Brigham Innovation | Series B, Series A |
| Catalio Capital Management | Series B |
| Novo Holdings | Series B, Series A |
| Aisling Capital | Series B |
| Adage Capital Management | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 20, 2026
Grew 233% QoQ, from 3 to 10 employees.
- Apr 22, 2026
Grew 600% QoQ from 1 to 7 employees.
Claris Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Claris Bio's valuation, stock price, and market status.